
G2’s Lab Institute Returns in Virtual Format
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
This digital event will help labs meet the various legal, compliance, business, and technology challenges of the industry, today and tomorrow.
It remains far from clear whether the new surprise billing rule goes far enough to fix the problem of insurers having too much power in disputes.
Revised final rule essentially disarms the threat of insurers having the advantage in out-of-network price disputes.
The process is now slightly less rigged in insurers’ favor.
The VALID Act for FDA regulation of laboratory developed tests is working its way through the final stages of the legislative process, but not everyone is loving it.